Inventor · disambiguated record
Susan Arnold
Also filed as: ARNOLD SUSAN · ARNOLD SUSAN ALISON
10 granted patents·8 pending applications·95 citations·filing 2007–2024
87Inventor score
Files withPHASEBIO PHARMACEUTICALS INC10PROCTER & GAMBLE3GEORGOPOULOS LYNNE M2ARCHER IAN VICTOR JAMES1ARNOLD SUSAN1
Top patents by PatentIndex Score
18 records- 0187USD827428SOver the counter medicine container with surface ornamentationPROCTER & GAMBLE·Filed 2017·Granted Sep 4, 2018·34 cites·1 claims
- 0287USD824251SOver the counter medicine container with surface ornamentationPROCTER & GAMBLE·Filed 2017·Granted Jul 31, 2018·34 cites·1 claims
- 0386US9919032B2Method for administering a sustained release formulationPHASEBIO PHARMACEUTICALS INC·Filed 2016·Granted Mar 20, 2018·3 cites·20 claims
- 0479US10688156B2Methods and compositions for treating muscle disease and disordersPHASEBIO PHARMACEUTICALS INC·Filed 2016·Granted Jun 23, 2020·2 cites·15 claims
- 0577USD826710SOver the counter medicine container with surface ornamentationPROCTER & GAMBLE·Filed 2017·Granted Aug 28, 2018·18 cites·1 claims
- 0677US2025332221A1Methods and compositions for treating muscle disease and disordersIMMUNOFORGE CO LTD·Filed 2024·Application pending·0 cites
- 0773US2022288170A1Methods and compositions for treating muscle disease and disordersPHASEBIO PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0872US9561262B2Use of modified vasoactive intestinal peptides in the treatment of hypertensionGEORGOPOULOS LYNNE M·Filed 2012·Granted Feb 7, 2017·4 cites·22 claims
- 0969US11266719B2Methods and compositions for treating muscle disease and disordersPHASEBIO PHARMACEUTICALS INC·Filed 2020·Granted Mar 8, 2022·0 cites·15 claims
- 1064US2022023390A1Methods and compositions for treating cystic fibrosisPHASEBIO PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1159US11052132B2Methods and compositions for treating cystic fibrosisPHASEBIO PHARMACEUTICALS INC·Filed 2015·Granted Jul 6, 2021·0 cites·16 claims
- 1258US2015290328A1Formulations of active agents for sustained releasePHASEBIO PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1353US10940182B2Use of modified vasoactive intestinal peptides in the treatment of hypertensionPHASEBIO PHARMACEUTICALS INC·Filed 2016·Granted Mar 9, 2021·0 cites·19 claims
- 1449US2014171370A1Formulations of active agents for sustained releasePHASEBIO PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1546US2013084277A1Formulations of active agents for sustained releaseARNOLD SUSAN·Filed 2012·Application pending·0 cites
- 1642US8133717B2Stereoinversion of amino acids in a single reactorARCHER IAN VICTOR JAMES·Filed 2007·Granted Mar 13, 2012·0 cites·24 claims
- 1740US2013090285A1Methods of treatment with glp-1 receptor agonistsGEORGOPOULOS LYNNE M·Filed 2012·Application pending·0 cites
- 1839US2015361154A1Therapeutic agents, compositions, and methods for glycemic controlPHASEBIO PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →